FDA approves Mesoblast's Ryoncil, the first U.S. MSC therapy, for children with steroid-refractory acute graft-versus-host disease. In a Phase 3 trial, 70% of SR-aGvHD patients responded to ...

Bank Indonesia Governor Perry Warjiyo vowed to cooperate with a corruption probe of the central bank, which was raided earlier this week by the country’s anti-graft agency. Warjiyo said the ...

Dec 18 (Reuters) - The U.S. Food and Drug Administration on Wednesday approved Mesoblast's (MSB.AX), opens new tab cell therapy for treating a type of complication that occurs after a stem cell or ...

CABG was performed using either pedicled internal mammary artery grafts or saphenous vein aortocoronary bypass grafts, without proximal ligation of the native coronary artery. Intraoperative graft ...